Next Article in Journal
The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
Next Article in Special Issue
Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and Beyond
Previous Article in Journal
Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma
Previous Article in Special Issue
Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors
 
 
Review

Article Versions Notes

Cancers 2021, 13(19), 4978; https://doi.org/10.3390/cancers13194978
Action Date Notes Link
article pdf uploaded. 4 October 2021 14:13 CEST Version of Record https://www.mdpi.com/2072-6694/13/19/4978/pdf-vor
article xml file uploaded 9 October 2021 08:36 CEST Original file -
article xml uploaded. 9 October 2021 08:36 CEST Update https://www.mdpi.com/2072-6694/13/19/4978/xml
article pdf uploaded. 9 October 2021 08:36 CEST Updated version of record https://www.mdpi.com/2072-6694/13/19/4978/pdf
article html file updated 9 October 2021 08:37 CEST Original file -
article html file updated 9 October 2021 10:07 CEST Update -
article html file updated 30 July 2022 09:17 CEST Update https://www.mdpi.com/2072-6694/13/19/4978/html
Back to TopTop